selegiline has been researched along with Cochlear Hearing Loss in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Farkas, J; Gáborján, A; Humli, V; Köles, L; Miklya, I; Polony, G; Szepesy, J; Szirmai, Á; Tábi, T; Tamás, L; Tímár, J; Vizi, ES; Zelles, T | 1 |
1 other study(ies) available for selegiline and Cochlear Hearing Loss
Article | Year |
---|---|
Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice.
Topics: Administration, Oral; Aging; Animals; Antiparkinson Agents; Auditory Threshold; Disease Models, Animal; Evoked Potentials, Auditory, Brain Stem; Hearing Loss, Sensorineural; Humans; Male; Mice, Inbred BALB C; Mice, Inbred DBA; Protective Agents; Selegiline; Synaptic Transmission | 2021 |